Career record

Output across his professional career to date.

  • 30,000Intermediates
  • 26Pre-clinical compounds
  • 6Clinical compounds
  • 2Phase-1 compounds
  • 1Phase-3 compound
  • 11Patents authored
  • 21Journal articles

Professional experience

  1. 2001–2003

    Post-Doctoral Researcher

    National Chung-Cheng University, Chia-yi, Taiwan

    Focused on developing new methodologies for natural product frameworks.

  2. 2003–2005

    Visiting Professor, Green Organic Synthesis Lab

    Hanyang University, Seoul, South Korea

    Specialised in organometallic chemistry, studying reaction mechanisms and pioneering new methodologies involving Pd, Pt, Rh and Au.

Areas of practice

Stakeholder Management

Collaborate with over 50 international working groups, including clients' external assignments, coordinating across various enabling functions.

API Development

Processes: development, tech transfer, synthesis of reference and stable label compounds. Compounds: unnatural amino acids, macromolecules, semi-synthetics, and high-potency compounds for oncology products and intermediates.

Process Development

Adhering to ICH-Q11 guidelines for toxicological, pre-toxicological, pre-clinical and clinical studies. Develops eco-friendly processes and performs safety studies, including Differential Scanning Calorimetry (DSC) to assess shock sensitivity and energy levels. Polymorphic studies cover SXRD, PXRD, Raman spectra, FBRM and real-time reaction monitoring.

Milestone Projects

Provides synthetic support for multiple partnering programs, managing 5–6 projects concurrently.

Work with us

Talk to our research team

Bring us a route problem, an intermediate you cannot source, or a programme that needs synthetic support.